Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction

British Journal of Anaesthesia

Volumn 99, Issue 3, 2007, Pages 316-328

  Chassot, Pierre Guy ^a   Delabays, A ^a   Spahn, D R ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Complications, haemorrhage; Complications, myocardial infarction; Coronary stenosis, drug therapy; Platelet aggregation inhibitors, therapeutic use; Surgery, non cardiac

Indexed keywords

3 [7 [2 (3,4 DIFLUOROPHENYL)CYCLOPROPYLAMINO] 5 PROPYLTHIO 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 3 YL] 5 HYDROXYMETHOXY 1,2 CYCLOPENTANEDIOL; ABCIXIMAB; ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; ANTITHROMBOCYTIC AGENT; APROTININ; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; EPTIFIBATIDE; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOBUFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PACLITAXEL; PARACETAMOL; PLACEBO; RAPAMYCIN; THIENO[3,2 C]PYRIDINE DERIVATIVE; TIROFIBAN;

BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY RISK; CORONARY STENT; DRUG DOSE INCREASE; DRUG ELUTING STENT; DRUG HALF LIFE; DRUG MEGADOSE; DRUG RECEPTOR BINDING; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; META ANALYSIS; MONOTHERAPY; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW; RHABDOMYOLYSIS; SIDE EFFECT; SPINAL HEMATOMA; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; UNSTABLE ANGINA PECTORIS;

EID: 34548251956     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem209     Document Type: Review

References (126)

1. ACC/AHA Guideline update for perioperative cardiovascular evaluation for non-cardiac surgery - executive summary. Circulation 2002; 105 1257-67
2. ACC/AHA/SCAI Guideline update for percutaneous coronary intervention. Executive summary. J Am Coll Cordiol 2006; 47: 216-35
3. AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006; 113: 2363-72
4. Agostini P, Biondi-Zoccai GGL, Gasparini GL, et al. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J 2005; 26: 881-9
5. Albaladejo P, Marret E, Piriou V, Samama CM. Perioperative management of antiplatelet agents in patients with coronary stents: Recommendations of a French Task Force. Br J Anaesth 2006; 97: 580-1
6. Antithrombotic Trialist's Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86
7. Antman EM, McCabe CH, Gurfinkel EP et al. Enoxaparin prevents death and cardiac ischaemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 1IB trial. Circulation 1999; 100: 1593-601
8. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006; 113: 1362-76
9. Bavry AA, Kumbhani DJ, Helton TJ, et al. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006; 119: 1056-61
10. Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: A meta-analysis. Anesth Analg 2001; 93 853-8
11. Belisle S, Hardy JF. Hemorrhage and the use of blood products after cardiac operations: Myths and realities. Ann Thorac Surg 1996; 62: 1908-17
12. Beving H, Zhao C, Albage A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996; 7: 80-4
13. Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The CHARISMA trial. N Engl J Med 2006; 354: 1706-17
14. Biodi-Zoccai GGL, Lotrionte M, Agostini P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74
15. Blake GJ, Ridker PM. Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 2002; 252: 283-94
16. Brilakis ES, Orford JL, Fasseas P, et al. Outcome of patients undergoing balloon angioplasty in the two months prior to non-cardiac surgery. Am J Cardiol 2005; 96: 512-4
17. Broad L, Lee T, Conroy M, et al. Successful management of patients with a drug-eluting stent presenting for elective non-cardiac surgery. Br J Anaesth 2007; 98: 19-22
18. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its preoperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Int Med 2005; 257: 399-414
19. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents. A cause of concern. Circulation 2007; 115: 1440-55
20. Chassot PG, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth 2002; 89: 747-59
21. Chassot PG, Delabays A, Spahn DR. Perioperative use of antiplatelet drugs. Best Pract Res Clin Anesthesiol 2007; 21: 241-56
22. Chu MWA, Wilson SR, Novick RJ, et al. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004; 78: 1536-41
23. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndrome. Circulation 2004; 110: 2361-7
24. Cooke GE, Liu-Stratton Y, Kerketich AK, et al. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their coombination. J Am Coll Cardiol 2006; 47: 541-6
25. Daemen J, Wenewaser P, Tsuchida K, et al. Early and late stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-78
26. Dawood MM, Gupta DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: Implications regarding physiopathology and prevention. Int J Cardiol 1996; 57: 37-44
27. Durazzo AES, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial. J Vasc Surg 2004; 39: 967-76
28. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-68
29. Ernst A, Eberhardt R, Wahidi M, et al. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129: 734-7
30. Faulds D, Sorkin EM. Abciximab (c7E3 Fab): A review of its pharmacology and therapeutic potential is ischaemic heart disease. Drugs 1994; 48: 583-98
31. Fatah K, Beving H, Albage A, et al. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur Heart J 1996; 17: 1362-6
32. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-9
33. Forestier F, Breton Y, Bonnet E, Janvier G. Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins. Anesthesiology 2002; 97: 1019-21
34. Fox J. Spinal and epidural anesthesia and anticoagulation. Int Anesthesiol Clin 2001; 39: 51-61
35. Genoni M, Zeller D, Bertel O, et al. Tirofiban therapy does not increase the risk of hemorrhage after emergency coronary surgery. J Thorac Cardiovasc Surg 2001; 122: 630-2
36. Giroud D, Li JM, Urban P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992; 69: 729-32
37. Gonzalez-Correa JA, Arrebola MM, Martin-Salido E, Munoz-Marin J, Sanchez de la Cuesta F, De La Cruz JP. Effects of dexibuprofen on platelet function in humans. Comparison with low-dose aspirin. Anesthesiology 2007; 106: 218-25
38. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000; 35: 157-63
39. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A Science Advisory from the American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007; 49: 734-9
40. Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy. Clin Pharmacokinet 2004; 43: 963-81
41. Harrington RA, Becker RC, Ezekowitz M, et al. Antithrombotic therapy for coronary artery disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 513S-48S
42. Heeschen C, Hamm CW, Laufs U, et al. Withdrawal of statins increases event rates in patient with acute coronary syndromes. Circulation 2002; 105: 1446-52
43. Hindler K, Shaw AD, Samuels J, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-72
44. Hodgson JMcB, Stone GW, Lincoff AM, et al. Late stent thrombosis: considerations and practical advice for use of drug-eluting stents: A report from the Society for Cardiovascular Angiography and Interventions Drug-eluting stent Task Force (Clinical Alert). Catheter Cardiovasc Interv 2007; 69: 327-33
45. Hoffmeister HM, Heller W, Seipel L. Activation markers of coagulation and fibrinolysis: Alterations and predictive value in acute coronary syndrome. Thromb Haemostasis 1999; 82: 76-9
46. Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative anti-platelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg 1995; 80: 303-9
47. Horlocker TT, Wedel DJ, Benson H. Regional anesthesia in anticoagulated patients: Defining the risks. Reg Anesth Pain Med 2003; 28: 172-98
48. Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW. Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007; 98 560-74
49. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30
50. Jernberg T, Payne CD, Winters KJ, Darstein C, et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 2006; 27: 166-73
51. Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real world setting: Randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005; 366: 921-9
52. Kallio H, Paloheimo M, Maunuksela. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: A prospective study in 1383 patients. Br J Anaesth 2000; 85: 708-11
53. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288-94
54. Kapetanakis El, Medlam DA, Boyce SW, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache? Eur Heart J 2005; 26: 576-83
55. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: Systematic review of controlled studies. Br Med J 2006; 333: 1149-56
56. Kearon C, Hirsh J. Current concepts: Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-11
57. Kersten JR, Fleisher LA. Statins: The next advance in cardioprotection? Anesthesiology 2006; 105: 1079-80
58. Kleinman NS. Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors. Am Heart J 1999; 138: 263-75
59. Kolodgie FD, Burke AP, Farb A, et al. The thin-cap fibroatheroma: a type of vulnerable plaque, the major precursor lesion to acute coronary syndrome. Curr Opin Cardiol 2001; 16: 285-92
60. Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents. J Am Coll Cardiol 2006; 47: 2108-11
61. Labarthe B, Théroux P, Angioï M, Ghitescu M. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol 2005; 46: 638-45
62. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Anesthesiology 2002; 97: 215-52
63. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents. N Engl J Med 2007; 356: 1009-19
64. Landesberg G. The pathophysiology of perioperative myocardial infarction: Facts and perspectives. J Cardiothorac Vasc Anesth 2003; 17: 90-100
65. Landesberg G, Shatz V, Avopnik I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003; 42: 1547-54
66. Lev El, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention. The role of dual drug resistance. J Am Coll Cardiol 2006; 47: 27-33
67. Lindblad B, Persson NH, Takolander R, Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind placebo-controlled, randomized study. Stroke 1993; 24: 1125-8
68. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-61
69. Manning BJ, O'Brien N, Aravindan S, et al. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 2004; 35: 121-4
70. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21
71. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001; 358: 527-33
72. Meier P, Zbinden R, Togni M, et al. Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol 2007; 49: 15-20
73. Michlig C, Vu DH, Wasserfallen JB, et al. Three years of haemovigilance in a general university hospital. Transfus Med 2003; 13: 63-72
74. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903
75. Moses JW, Stone GW, Nikolsky E, et al. Drug-eluting stents in the treatment of intermediate lesions. Pooled analysis from four randomized trials. J Am Coll Cardiol 2006; 47: 2164-71
76. Murphy JT, Brenda GF. Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit. Anesth Analg 2005; 101: 971-3
77. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies. Part I. Circulation 2003; 108: 1664-72
78. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: A decision analysis. Anesth Analg 2001; 93: 573-80
79. Newsome LT, Kutcher MA, Gandhi SK, Prielipp RC, Royster RL. A protocol for the perioperative management of patients with intracoronary drug-eluting stents. Anesthesia Patient Safety Foundation. APSF Newsletter 2006; 4: 81-2
80. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs bare metal stents in coronary artery disease: A meta-analysis. Eur Heart J 2006; 27: 2784-814
81. Nutall GA, Horlocker TT, Santrach PJ, et al. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 2000; 25: 596-601
82. Nutall GA, Santrach PJ, Oliver WC, Jr, et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996; 36: 144-9
83. Ollausson K, Magnusdottir H, Lurje L, et al. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris. Circulation 1997; 96: 2178-82
84. Ong ATL, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-92
85. Palmer JD, Sparrow OC, Iannotti F. Postoperative hematoma: A 5-year survey identification of avoidable risk factors. Neurosurgery 1994; 35: 1061-4
86. Park WY, Thompson JS, Lee KK. Effect of epidural anesthesia and analgesia on perioperative outcome: A randomized, controlled Veteran Affairs cooperative study. Ann Surg 2001; 234: 560-9
87. Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation 2003; 108 1682-7
88. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 2006; 48: 2584-91
89. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107: 1848-51
90. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341 1789-94
91. Popma JJ, Berger P, Ohman EM, et al. Antithrombotic therapy during percutaneous coronary intervention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 576S-99S
92. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999; 89: 553-60
93. Priebe HJ. Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth 2004; 93: 9-20
94. Priebe HJ. Perioperative myocardial infarction - aetiology and prevention. Br J Anaesth 2005; 95: 3-19
95. Qureshi A, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002; 33: 1916-9
96. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. Br Med J 2000; 321: 1493
97. Rodondi N, Cornuz J. Place de I'aspirine en prévention primaire des maladies cardiovasculaires. Rev Méd Suisse 2006; 2: 646-51
98. Samama CM. Preoperative nonsteroidal antiinflammatory agents as substitutes for aspirin. Already too late? Anesthesiology 2007; 106: 205-6
99. Samama CM, Djoudi R, Lecompte T, Nathan N, Schved JF. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency 2003. Minerva Anesthesiol 2006; 72: 447-52
100. Sandhu JS, Ng CK, Gonzales RR, et al. Photoselective laser vaporisation prostatectomy in men receiving anticoagulants. J Endourol 2005; 19: 1196-8
101. Serruys PW, Kutryk MJB, Ong ATL. Coronary artery stents. N Engl J Med 2006; 354: 483-95
102. Serruys PW, Daemen J. Late stent thrombosis. A nuisance in both bare metal and drug-eluting stents. Circulation 2007; 115: 1433-9
103. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: When is it safe to operate? Catheter Cardiovasc Interv 2004; 63: 141-5
104. Shuchman M. Trading restenosis for thrombosis? New questions about drug-eluting stents. N Engl J Med 2006; 355: 19949-52
105. Shuchman M. Debating the risks of drug-eluting stents. N Engl J Med 2007; 356: 325-8
106. Silber S, Albertsson P Avilès FF, et al. Guidelines for percutaneous interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47
107. Société Francophone de Médecine Buccale et de Chirurgie Buccale. Prise en charge des patients sous agents antiplaquettaires en odontostomatologie. Recommandations. Méd Bucc Chir Bucc 2005; 11: 1-22
108. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 989-97
109. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation 2006; 113: 2803-9
110. Stage J, Jensen JH, Bonding P. Post-tonsillectomy haemorrhage and analgesics. A comparative study of acetylsalicylic acid and paracetamol. Clin Otolaryngol 1988; 13: 201-4
111. Steinbuhl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized trial (CREDO). JAMA 2002; 288: 2411-20
112. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008
113. Tam NLK, Pac-Soo C, Pretorius PM. Epidural haematoma after a combined spinal-epidural anaesthtic in a patient treated with clopidogrel and dalteparin. Br J Anaesth 2006; 96: 262-5
114. Tcheng JE, Talley JD, O'Shea JC, et al. Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study). Am J Cordial 2001; 88: 1097-102
115. Thurston AV, Briant SL. Aspirin and post-prostatectomy haemorrhage. Br J Urol 1993; 71: 574-6
116. Tyagi A, Bhattacharya A. Central neuraxial blocks and anticoagulation: A review of current trends. Eur J Anaesthesiol 2002; 19: 317-29
117. Ueda Y, Nanto S, Komamura K, et al. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994; 23: 341-6
118. Valerin MA, Brennan MT, Noll JL, et al. Relationship between aspirin use and postoperative bleeding from dental extraction in a healthy population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 326
119. Van der Linden J, Lindvall G, Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: A double-blind, placebo-controlled, randomized clinical trial. Circulation 2005; 112: 1276-80
120. Vial JH, McLeod LJ, Roberts MS. Rebound elevation in urinary thromboxane B2 and 6-keto-PFFI alpha exacerbation after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res 1991; 21A: 157-60
121. Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96: 686-93
122. Weber AA, Braun M, Hohlfeld T, et al. Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. Br J Clin Pharmacol 2001; 52: 333-6
123. Wanaweser P, Dörffler-Melly J, Imboden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cordial 2005; 45: 1748-52
124. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42: 234-40
125. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29: 2271-5
126. Yusuf S, Zhao F, Mehta SR, et al. CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502